http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2376990-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_721c0552a2262565aeda21822542f545 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16 |
| filingDate | 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c4f383ac8670db11858050f29385d54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5113a1690880fd7cb1693f8943d60de |
| publicationDate | 2009-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2376990-C2 |
| titleOfInvention | Application of vinpocetine for prevention of complications, in particular hearing-related complications, accompanying epilepsy and its treatment |
| abstract | FIELD: medicine. n SUBSTANCE: application of vinpocetine is proposed for treatment of changes of retro-cochlear origin, related with epilepsy, characterised by inhibiting changes of amplitudes and latencies of late waves of hearing answer of brainstem (HAB), which accompany convulsions and for treatment of loss of hearing, characterised by inhibiting of hearing threshold increase, induced during convulsions. n EFFECT: vinpocetine inhibits all changes of HAB waves, which accompany cortical epileptic activity during ictal and post-ictal periods, also inhibits evident loss of hearing and changes of characteristics on EEG, induced by two convulsive agents, which differ by their mechanism of acting. n 4 cl, 7 dwg, 6 tbl, 2 ex |
| priorityDate | 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.